Ampio Pharmaceuticals (FRA:APH0) Total Operating Expense: €8.84 Mil (TTM As of Dec. 2023)


FRA:APH0 Ampio Pharmaceuticals Inc FRA:APH0
35 GF Score
Price €3.62
View Full Analysis

What is Ampio Pharmaceuticals Total Operating Expense?

Ampio Pharmaceuticals FRA:APH0 35 Total Operating Expense is €8.84 Mil as of Dec. 2023. GuruFocus rates FRA:APH0 with a GF Score™ of 35/100.

Ampio Pharmaceuticals's Total Operating Expense for the three months ended in Dec. 2023 was €2.03 Mil. Ampio Pharmaceuticals's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €8.84 Mil.

Ampio Pharmaceuticals Total Operating Expense Related Terms

Ampio Pharmaceuticals Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Ampio Pharmaceuticals's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ampio Pharmaceuticals Total Operating Expense Chart

Ampio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.72 13.02 18.21 19.24 8.73

Ampio Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.55 4.06 1.44 1.31 2.03
FRA:APH0
35GF Score
Ampio Pharmaceuticals Inc FRA:APH0
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ampio Pharmaceuticals Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €8.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €8.84 Mil mean?
Ampio Pharmaceuticals (FRA:APH0) has a Total Operating Expense of €8.84 Mil as of Dec. 2023. Total operating expense is the primary recurring expense associated with central operations. View historical data on Ampio Pharmaceuticals and its competitors.
Is Ampio Pharmaceuticals' Total Operating Expense too high?
Ampio Pharmaceuticals' current Total Operating Expense is €8.84 Mil. Overall, Ampio Pharmaceuticals has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Ampio Pharmaceuticals' Total Operating Expense compare to EFTR and VBIVQ?
Ampio Pharmaceuticals' Total Operating Expense of €8.84 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Ampio Pharmaceuticals and its competitors. Ampio Pharmaceuticals's current Total Operating Expense is €8.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ampio Pharmaceuticals stock overvalued right now?
Ampio Pharmaceuticals (FRA:APH0) has a current Total Operating Expense of €8.84 Mil. The current Total Operating Expense is €8.84 Mil. Ampio Pharmaceuticals' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Ampio Pharmaceuticals (FRA:APH0), the current Total Operating Expense is €8.84 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ampio Pharmaceuticals Business Description

Address 9800 Mount Pyramid Court, Suite 400, Englewood, CO, USA, 80112
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee (OAK) as part of its OA-201 development program (OA-201 program or OA-201).
35GF Score

Get the complete analysis for FRA:APH0

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.62
Price